Blue Jet Healthcare Limited (NSE:BLUEJET)

Market Cap	133.59B
Revenue (ttm)	10.76B
Net Income (ttm)	3.05B
Shares Out	173.47M
EPS (ttm)	17.59
PE Ratio	43.78
Forward PE	35.37
Dividend	1.00 (0.13%)
Ex-Dividend Date	n/a

Volume	2,820,558
Average Volume	579,470
Open	789.00
Previous Close	770.15
Day's Range	785.10 - 844.80
52-Week Range	347.60 - 968.30
Beta	n/a
RSI	63.33
Earnings Date	May 30, 2025

About Blue Jet Healthcare

Blue Jet Healthcare Limited engages in the manufacturing and sale of pharmaceutical intermediates and active pharmaceutical ingredients (APIs) for use in pharmaceutical and healthcare products. It provides contrast media intermediates; niche pharmaceutical intermediates and APIs; and CDMO/CMO services, as well as end-to-end solutions from process development and commercialization of NCEs, advance intermediates, API, and building blocks. The company develops, manufactures, and markets saccharin and related salts. It has operations in India, Norw...

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 1968
• Employees: 447
• Stock Exchange: National Stock Exchange of India
• Ticker Symbol: BLUEJET

Financial Performance

In 2023, Blue Jet Healthcare's revenue was 7.12 billion, a decrease of -1.30% compared to the previous year's 7.21 billion. Earnings were 1.64 billion, an increase of 2.33%.